These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 18441772

  • 1. Efficacy and safety of dapsone gel 5% for the treatment of acne vulgaris in adolescents.
    Raimer S, Maloney JM, Bourcier M, Wilson D, Papp K, Siegfried E, Garrett S, United States/Canada Dapsone Gel Study Group.
    Cutis; 2008 Feb; 81(2):171-8. PubMed ID: 18441772
    [Abstract] [Full Text] [Related]

  • 2. The efficacy and tolerability of dapsone 5% gel in female vs male patients with facial acne vulgaris: gender as a clinically relevant outcome variable.
    Tanghetti E, Harper JC, Oefelein MG.
    J Drugs Dermatol; 2012 Dec; 11(12):1417-21. PubMed ID: 23377510
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults With Acne Vulgaris: Second of Two Identically Designed, Large, Multicenter, Randomized, Vehicle-Controlled Trials.
    Eichenfield LF, Lain T, Frankel EH, Jones TM, Chang-Lin JE, Berk DR, Ruan S, Kaoukhov A.
    J Drugs Dermatol; 2016 Aug 01; 15(8):962-9. PubMed ID: 27537997
    [Abstract] [Full Text] [Related]

  • 4. Dapsone gel 5% for the treatment of acne vulgaris: safety and efficacy of long-term (1 year) treatment.
    Lucky AW, Maloney JM, Roberts J, Taylor S, Jones T, Ling M, Garrett S, Dapsone Gel Long-Term Safety Study Group.
    J Drugs Dermatol; 2007 Oct 01; 6(10):981-7. PubMed ID: 17966175
    [Abstract] [Full Text] [Related]

  • 5. Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris.
    Draelos ZD, Carter E, Maloney JM, Elewski B, Poulin Y, Lynde C, Garrett S, United States/Canada Dapsone Gel Study Group.
    J Am Acad Dermatol; 2007 Mar 01; 56(3):439.e1-10. PubMed ID: 17208334
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults With Acne Vulgaris: First of Two Identically Designed, Large, Multicenter, Randomized, Vehicle-controlled Trials.
    Stein Gold LF, Jarratt MT, Bucko AD, Grekin SK, Berlin JM, Bukhalo M, Weiss JS, Berk DR, Chang-Lin JE, Lin V, Kaoukhov A.
    J Drugs Dermatol; 2016 May 01; 15(5):553-61. PubMed ID: 27168264
    [Abstract] [Full Text] [Related]

  • 7. Treatment Response With Once-Daily Topical Dapsone Gel, 7.5% for Acne Vulgaris: Subgroup Analysis of Pooled Data from Two Randomized, Double-Blind Stu.
    Draelos ZD, Rodriguez DA, Kempers SE, Bruce S, Peredo MI, Downie J, Chang-Lin JE, Berk DR, Ruan S, Kaoukhov A.
    J Drugs Dermatol; 2017 Jun 01; 16(6):591-598. PubMed ID: 28686777
    [Abstract] [Full Text] [Related]

  • 8. Dapsone 5% gel: a review of its efficacy and safety in the treatment of acne vulgaris.
    Stotland M, Shalita AR, Kissling RF.
    Am J Clin Dermatol; 2009 Jun 01; 10(4):221-7. PubMed ID: 19489655
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Use of Dapsone 5% Gel as Maintenance Treatment of Acne Vulgaris Following Completion of Oral Doxycycline and Dapsone 5% Gel Combination Treatment.
    Kircik LH.
    J Drugs Dermatol; 2016 Feb 01; 15(2):191-5. PubMed ID: 26885787
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Once-Daily Topical Dapsone Gel, 7.5%: Effective for Acne Vulgaris Regardless of Baseline Lesion Count, With Superior Efficacy in Females.
    Tanghetti E, Harper J, Baldwin H, Kircik L, Bai Z, Alvandi N.
    J Drugs Dermatol; 2018 Nov 01; 17(11):1192-1198. PubMed ID: 30500140
    [Abstract] [Full Text] [Related]

  • 20. Once-Daily Topical Dapsone Gel, 7.5%: Effective for Acne Vulgaris Regardless of Baseline Lesion Count, With Superior Efficacy in Females.
    Tanghetti E, Harper J, Baldwin H, Kircik L, Bai Z, Alvandi N.
    J Drugs Dermatol; 2018 Nov 01; 17(11):1192-1198. PubMed ID: 30500141
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.